Developer docs
API playgroundTry for free, no card

Search company profiles

Dyad

Full company profile

uuid0000pb1

Namestring
Dyad
Legal namestring
Dyad AI, Inc.
Websiteurl
dyad.net
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Dyad (legally Dyad AI, Inc.) is a healthcare-focused AI company that builds clinical document and data intelligence software for healthcare payers, providers, and accountable care organizations (ACOs). Its core platform, ALIS DX, transforms unstructured clinical text into structured SNOMED, ICD-10, and CPT codes and uses the resulting structured data to calculate quality measures (HEDIS, MIPS, eCQMs), close care gaps, support Star Ratings improvement, and improve coder throughput. The platform is powered by a proprietary technology called GENIE (Graph Enabled Information Extraction), which combines natural language processing with a clinical knowledge graph to handle complex outpatient coding without hallucination, with outputs delivered directly into customers' existing EHRs, applications, and data lakes.

The company operates a subscription-based, enterprise SaaS model with quote-based pricing and an annual billing cadence, selling through a direct consultative sales motion that funnels prospects into demo bookings. Its named flagship deployment is the BetterLetter application, powered by Dyad, which codes and workflows millions of pieces of NHS clinical correspondence per year across hundreds of UK primary care clinics. In November 2025, Dyad extended ALIS DX with an Email Triage Agent and Extractor module targeting insurance intermediaries (MGAs, wholesalers, and program admins), signaling a deliberate horizontalization of its document intelligence capabilities beyond pure clinical coding.

Dyad was founded in 2020 and is headquartered in London, United Kingdom, while its legal entity is incorporated in the United States. The company maintains HIPAA, SOC2 Type 2, and Cyber Essentials Plus certifications, positioning it for both US payer/provider sales and UK public-sector healthcare procurement. Funding to date totals approximately $4 million across 2020-2021 from Plug and Play, Carbide Ventures, Pantera Capital, and Sangha Capital, with no subsequent priced rounds disclosed in the source material.

Short descriptiontext

Dyad (Dyad AI, Inc.) is a healthcare AI company whose ALIS DX platform, powered by its proprietary GENIE technology, converts unstructured clinical documents into standardized medical codes and quality insights for payers, providers, ACOs, and now insurance intermediaries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
clinical document intelligence, healthcare AI platform, clinical coding automation, value-based care analytics, EHR data integration
Industry2 codes
1Electronic Data Capture (EDC) Platforms
CodeHLACAOAAPrimaryYes
2DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA)
CodeHLACANANPrimaryNo
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare AI / Clinical Document Intelligence
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Healthcare AI Platform Subscription
TypeSubscription Recurring
Description

SaaS platform subscription model providing AI-powered clinical document intelligence to healthcare payers, providers, and ACOs. The ALIS DX platform embeds AI capabilities directly into existing workflows, with pricing likely tiered by volume or functionality.

dyad.ai
2ALIS DX Platform Licensing
TypeSubscription Recurring
Description

Licensing of ALIS DX platform featuring AI capabilities for email and document processing, targeting MGAs, wholesalers, and program administrators in the insurance space.

einpresswire.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Quote-based enterprise pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing not publicly disclosed. Sales process initiates with demo booking, suggesting enterprise/negotiated pricing model.

dyad.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1ALIS DX
Description

AI platform with email and document processing capabilities for MGAs, wholesalers, and program admins, featuring Email Triage Agent and Extractor

dyad.ai
+2 more records
Core offering1 text field

Dyad sells the ALIS DX platform, an AI-powered clinical document and data intelligence solution that uses its proprietary GENIE technology to extract medical entities from unstructured clinical documents and output structured SNOMED, ICD-10, and CPT codes. The platform delivers real-time quality measurement, Star ratings improvement, care gap closure, RADV readiness, and coder productivity tools to healthcare payers, providers, ACOs, and insurance intermediaries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Dramatically reduced manual chart review
+2 more records
Product overview1 text field

Dyad offers a unified AI-powered platform called ALIS DX for clinical document and data intelligence in healthcare. The platform is powered by the proprietary GENIE (Graph Enabled Information Extraction) technology, which combines graph-based knowledge representation with natural language processing to extract and code clinical data from unstructured documents. ALIS DX serves payers, providers, and ACOs through modules including real-time quality measurement (HEDIS, MIPS, eCQMs), Star ratings optimization, care gap closure, RADV readiness, and coder productivity tools. The Email Triage Agent and Extractor module extends the platform's capabilities to insurance intermediaries for automated email and document processing.

Product and service2 records
1ALIS DX
CategoryHealthcare AI Platform / Clinical Document Intelligence
Description

AI-powered clinical document and data intelligence platform that transforms unstructured healthcare data into structured SNOMED, ICD-10, and CPT codes, enabling real-time quality measurement (HEDIS, MIPS, eCQMs), Star ratings improvement, care gap closure, RADV readiness, and coder productivity for healthcare payers, providers, ACOs, and insurance intermediaries.

2Email Triage Agent and Extractor
CategoryInsurance Workflow Automation
Description

AI-powered module within ALIS DX that automates email triage and document extraction for insurance intermediaries (MGAs, wholesalers, program administrators), improving processing accuracy and reducing response times.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

BetterLetter is an application powered by Dyad's AI technology, used by hundreds of NHS primary care clinics to code and workflow millions of pieces of clinical correspondence per year. This represents a technology partnership where Dyad provides the underlying AI platform for clinical document intelligence.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Acquired by Microsoft, Nuance provides Dragon Medical One and DAX Copilot — clinical NLP and ambient documentation AI for healthcare providers. Overlaps with Dyad's clinical document intelligence and EHR-integrated AI workflows.

TypeEmerging player
Description

AI platform for healthcare revenue cycle management automating authorization, coding and billing workflows for providers. Comparable to Dyad in targeting healthcare administrative automation with AI-driven document processing.

TypeBroad incumbent
Description

Optum offers risk adjustment, HEDIS/Star quality measurement and clinical analytics at massive scale for payers and providers. Directly comparable to Dyad's quality-measurement and RADV/HEDIS use cases, but at incumbent scale.

TypeEmerging player
Description

AI platform automating hospital operations including patient intake, scheduling and clinical documentation. Comparable to Dyad in applying AI to healthcare administrative workflows and EHR-integrated process automation.

TypeEmerging player
Description

AI-driven prior authorization and clinical intelligence platform for payers and providers. Comparable to Dyad in using AI/NLP to streamline payer-provider workflows and reduce administrative friction in healthcare.

TypeEmerging player
Description

AI voice assistant for clinicians that automates clinical documentation and integrates with EHRs. Comparable to Dyad in using AI to reduce clinician documentation burden and produce structured clinical output.

TypeBroad incumbent
Description

AWS-managed NLP service extracting medical entities and codes from unstructured clinical text. Directly comparable to GENIE's core NLP capability but offered as a commoditized cloud API rather than a healthcare-specialized SaaS platform.

TypeDirect peer
Description

Spun off from 3M in 2024, Solventum (formerly 3M HIS) is a dominant clinical coding and health information systems vendor offering computer-assisted coding, NLP and revenue cycle solutions — directly comparable to Dyad's GENIE-based clinical coding platform for providers and payers.

TypeDirect peer
Description

Healthcare data activation platform unifying clinical, claims and social data for payers, providers and ACOs. Comparable to Dyad in building a structured data layer to enable quality measurement, care gap closure and value-based care analytics.

TypeRegional player
Description

Healthcare revenue cycle management platform including coding, claims and analytics for US providers. Comparable to Dyad's administrative automation and clinical data integrity use cases, primarily serving the US market with broader RCM scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dyad

Healthcare AI / Clinical Document Intelligencedyad.net

Dyad (Dyad AI, Inc.) is a healthcare AI company whose ALIS DX platform, powered by its proprietary GENIE technology, converts unstructured clinical documents into standardized medical codes and quality insights for payers, providers, ACOs, and now insurance intermediaries.

What Dyad does

Dyad (legally Dyad AI, Inc.) is a healthcare-focused AI company that builds clinical document and data intelligence software for healthcare payers, providers, and accountable care organizations (ACOs). Its core platform, ALIS DX, transforms unstructured clinical text into structured SNOMED, ICD-10, and CPT codes and uses the resulting structured data to calculate quality measures (HEDIS, MIPS, eCQMs), close care gaps, support Star Ratings improvement, and improve coder throughput. The platform is powered by a proprietary technology called GENIE (Graph Enabled Information Extraction), which combines natural language processing with a clinical knowledge graph to handle complex outpatient coding without hallucination, with outputs delivered directly into customers' existing EHRs, applications, and data lakes.

The company operates a subscription-based, enterprise SaaS model with quote-based pricing and an annual billing cadence, selling through a direct consultative sales motion that funnels prospects into demo bookings. Its named flagship deployment is the BetterLetter application, powered by Dyad, which codes and workflows millions of pieces of NHS clinical correspondence per year across hundreds of UK primary care clinics. In November 2025, Dyad extended ALIS DX with an Email Triage Agent and Extractor module targeting insurance intermediaries (MGAs, wholesalers, and program admins), signaling a deliberate horizontalization of its document intelligence capabilities beyond pure clinical coding.

Dyad was founded in 2020 and is headquartered in London, United Kingdom, while its legal entity is incorporated in the United States. The company maintains HIPAA, SOC2 Type 2, and Cyber Essentials Plus certifications, positioning it for both US payer/provider sales and UK public-sector healthcare procurement. Funding to date totals approximately $4 million across 2020-2021 from Plug and Play, Carbide Ventures, Pantera Capital, and Sangha Capital, with no subsequent priced rounds disclosed in the source material.

Dyad firmographics

Firmographics
Name
Dyad
Legal name
Dyad AI, Inc.
Website
https://dyad.net
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Dyad (Dyad AI, Inc.) is a healthcare AI company whose ALIS DX platform, powered by its proprietary GENIE technology, converts unstructured clinical documents into standardized medical codes and quality insights for payers, providers, ACOs, and now insurance intermediaries.
Ownership category
akta.pro rank

Dyad industry classification

Industry
Product category
Healthcare AI / Clinical Document Intelligence
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro primary industry
Electronic Data Capture (EDC) Platforms (HLACAOAA)
akta.pro secondary industry
DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA) (HLACANAN)

Keywords

  • Clinical document intelligence
  • Healthcare AI platform
  • Clinical coding automation
  • Value-based care analytics
  • EHR data integration

Where Dyad is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

Dyad business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Healthcare AI Platform Subscription: SaaS platform subscription model providing AI-powered clinical document intelligence to healthcare payers, providers, and ACOs. The ALIS DX platform embeds AI capabilities directly into existing workflows, with pricing likely tiered by volume or functionality.
  2. ALIS DX Platform Licensing: Licensing of ALIS DX platform featuring AI capabilities for email and document processing, targeting MGAs, wholesalers, and program administrators in the insurance space.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualQuote-based enterprise pricing

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Dyad product offering

Product offering

Core offering

Dyad sells the ALIS DX platform, an AI-powered clinical document and data intelligence solution that uses its proprietary GENIE technology to extract medical entities from unstructured clinical documents and output structured SNOMED, ICD-10, and CPT codes. The platform delivers real-time quality measurement, Star ratings improvement, care gap closure, RADV readiness, and coder productivity tools to healthcare payers, providers, ACOs, and insurance intermediaries.

Product overview

Dyad offers a unified AI-powered platform called ALIS DX for clinical document and data intelligence in healthcare. The platform is powered by the proprietary GENIE (Graph Enabled Information Extraction) technology, which combines graph-based knowledge representation with natural language processing to extract and code clinical data from unstructured documents. ALIS DX serves payers, providers, and ACOs through modules including real-time quality measurement (HEDIS, MIPS, eCQMs), Star ratings optimization, care gap closure, RADV readiness, and coder productivity tools. The Email Triage Agent and Extractor module extends the platform's capabilities to insurance intermediaries for automated email and document processing.

Differentiator

Problem solved

Functional benefit

Brands

  • ALIS DX: AI platform with email and document processing capabilities for MGAs, wholesalers, and program admins, featuring Email Triage Agent and Extractor
  • GENIE
  • BetterLetter

Products and services

  • ALIS DX AI-powered clinical document and data intelligence platform that transforms unstructured healthcare data into structured SNOMED, ICD-10, and CPT codes, enabling real-time quality measurement (HEDIS, MIPS, eCQMs), Star ratings improvement, care gap closure, RADV readiness, and coder productivity for healthcare payers, providers, ACOs, and insurance intermediaries.
  • Email Triage Agent and Extractor AI-powered module within ALIS DX that automates email triage and document extraction for insurance intermediaries (MGAs, wholesalers, program administrators), improving processing accuracy and reducing response times.

Quantifiable outcome

  • Dramatically reduced manual chart review
  • +2 more outcomes

Companies that use Dyad

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles5 records

Dyad technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Dyad partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • BetterLettercoreTechnology or IntegrationBetterLetter is an application powered by Dyad's AI technology, used by hundreds of NHS primary care clinics to code and workflow millions of pieces of clinical correspondence per year. This represents a technology partnership where Dyad provides the underlying AI platform for clinical document intelligence.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Dyad competitors and assessment

Company assessment

Broad incumbents

  • Nuance Communications (Microsoft): Acquired by Microsoft, Nuance provides Dragon Medical One and DAX Copilot — clinical NLP and ambient documentation AI for healthcare providers. Overlaps with Dyad's clinical document intelligence and EHR-integrated AI workflows.
  • Optum (UnitedHealth Group): Optum offers risk adjustment, HEDIS/Star quality measurement and clinical analytics at massive scale for payers and providers. Directly comparable to Dyad's quality-measurement and RADV/HEDIS use cases, but at incumbent scale.
  • Amazon Comprehend Medical: AWS-managed NLP service extracting medical entities and codes from unstructured clinical text. Directly comparable to GENIE's core NLP capability but offered as a commoditized cloud API rather than a healthcare-specialized SaaS platform.

Emerging players

  • AKASA: AI platform for healthcare revenue cycle management automating authorization, coding and billing workflows for providers. Comparable to Dyad in targeting healthcare administrative automation with AI-driven document processing.
  • Notable: AI platform automating hospital operations including patient intake, scheduling and clinical documentation. Comparable to Dyad in applying AI to healthcare administrative workflows and EHR-integrated process automation.
  • Cohere Health: AI-driven prior authorization and clinical intelligence platform for payers and providers. Comparable to Dyad in using AI/NLP to streamline payer-provider workflows and reduce administrative friction in healthcare.
  • Suki AI: AI voice assistant for clinicians that automates clinical documentation and integrates with EHRs. Comparable to Dyad in using AI to reduce clinician documentation burden and produce structured clinical output.

Direct peers

  • 3M Health Information Systems (Solventum): Spun off from 3M in 2024, Solventum (formerly 3M HIS) is a dominant clinical coding and health information systems vendor offering computer-assisted coding, NLP and revenue cycle solutions — directly comparable to Dyad's GENIE-based clinical coding platform for providers and payers.
  • Innovaccer: Healthcare data activation platform unifying clinical, claims and social data for payers, providers and ACOs. Comparable to Dyad in building a structured data layer to enable quality measurement, care gap closure and value-based care analytics.

Regional players

  • Waystar: Healthcare revenue cycle management platform including coding, claims and analytics for US providers. Comparable to Dyad's administrative automation and clinical data integrity use cases, primarily serving the US market with broader RCM scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Dyad social profiles

Digital presence

Dyad compliance and trust

Trust signal

Compliance3 records

Dyad financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dyad leadership team

Management profile

Number of profiles

Profiles1 record

Dyad funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dyad M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dyad

What does Dyad do?

Dyad sells the ALIS DX platform, an AI-powered clinical document and data intelligence solution that uses its proprietary GENIE technology to extract medical entities from unstructured clinical documents and output structured SNOMED, ICD-10, and CPT codes. The platform delivers real-time quality measurement, Star ratings improvement, care gap closure, RADV readiness, and coder productivity tools to healthcare payers, providers, ACOs, and insurance intermediaries.

Is Dyad a public or private company?

Dyad is a private company. It is classified as venture growth investor backed and is currently operating.

When was Dyad founded?

Dyad was founded in 2020. It employs 1 to 10 people.

Where is Dyad based?

Dyad is headquartered in London, United Kingdom, in the Europe region.

How does Dyad make money?

Two revenue lines are on record. Healthcare AI Platform Subscription is the primary driver. The others are ALIS DX Platform Licensing.

Who are Dyad's main competitors?

Broad incumbents on record are Nuance Communications (Microsoft), Optum (UnitedHealth Group) and Amazon Comprehend Medical. Emerging players are AKASA, Notable, Cohere Health and Suki AI. Direct peers are 3M Health Information Systems (Solventum) and Innovaccer. Waystar is listed as a regional player.

Does Dyad have an API?

No public API is recorded for Dyad.

What industry is Dyad in?

Dyad's product category is Healthcare AI / Clinical Document Intelligence. Its primary akta.pro industry code is HLACAOAA, Electronic Data Capture (EDC) Platforms, with a secondary code of HLACANAN, DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals